You are here

  • Home
  • Online First
  • Efficacy and safety of therapies for Still’s disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still’s disease

Citation Tools

Article menu
Inflammatory arthritis
Efficacy and safety of therapies for Still’s disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still’s disease

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Bindoli S, De Matteis A, Mitrovic S, et al
Efficacy and safety of therapies for Still’s disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still’s disease
Annals of the Rheumatic Diseases Published Online First: 24 September 2024. doi: 10.1136/ard-2024-225854